89bio, Inc.

Home » 89bio, Inc.

IPO

89bio, Inc.

Biopharmaceutical

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.

Symbol

ETNB

Price Range
$15.00 - $17.00

Final Shares
4,375,000

Anticipated Date
November 6, 2019

Underwriters
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED,LEERINK SWANN & COMPANY

To view the prospectus for 89bio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253